Disease modifying treatments and symptomatic drugs for cognitive impairment in multiple sclerosis: where do we stand?
Crossref DOI link: https://doi.org/10.1186/s40893-017-0025-3
Published Online: 2017-06-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Niccolai, Claudia http://orcid.org/0000-0003-2746-7500
Goretti, Benedetta
Amato, Maria Pia